Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhonghuan Biotechnology Co., Ltd. is a Chinese biotechnology company that specializes in the development and manufacture of molecular biology reagents and in vitro diagnostic (IVD) products. Founded in 2004 and based in Beijing, the company provides a wide range of products including DNA/RNA extraction kits, PCR-based diagnostic assays, and laboratory consumables. Zhonghuan Biotech serves clinical laboratories, research institutions, and hospitals, focusing on areas such as infectious disease screening and genetic analysis. The company also offers molecular biology services, including sequencing and synthesis, to support the life sciences research community in China. Its product portfolio is particularly strong in pathogen detection, including kits for Human Papillomavirus (HPV) and Hepatitis B Virus (HBV).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 中寰生物技术.